 Agile Therapeutics is preparing to launch their first FDA approved product, Twirla. If all goes well, Twirla could quickly establish a foothold in a 4.1B addressable market. Launching an FDA approved product is not easy and has plenty of unknowns. I point out some things to keep an eye out for before and after Twirlas launch. 